Reduced nitrate level in individuals with hypertension and diabetes

Journal of Cardiovascular Disease Research

Volumn 2, Issue 3, 2011, Pages 172-176

  Ayub, Shiekh Gazalla ^a   Ayub, Taha ^b   Khan, Saquib Naveed ^c   Dar, Rubiya ^a   Andrabi, Khurshid Iqbal ^a  

^a UNIVERSITY OF KASHMIR   (India)

^b GOVERNMENT MEDICAL COLLEGE   (India)

^c SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Diabetes; hypertension; nitric oxide

Indexed keywords

NITRATE; NITRIC ACID SYNTHASE; NITRIC OXIDE; SYNTHETASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERGLYCEMIA; ION PAIR CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; METABOLITE; PRIORITY JOURNAL; TURNOVER TIME;

EID: 80054019934     PISSN: 09753583     EISSN: 09762833     Source Type: Journal    
DOI: 10.4103/0975-3583.85264     Document Type: Article

References (39)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
2. Nathan C, Xie QW. Nitric oxide synthases: Roles, tolls and controls. Cell 1994;78:95-118.
3. Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys. Acta 1999;1411:217-30. (Pubitemid 29221951)
4. Cooke JP, Dzau VJ. Nitric oxide synthase: Role in the genesis of vascular disease. Annu Rev Med 1997;48:489-509. (Pubitemid 27101848)
5. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-5. (Pubitemid 21914599)
6. Garg UC, Hassid A. Nitric oxide generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-7. (Pubitemid 19124139)
7. Tanner FC, Meier P, Greutert H, Champion C, Nabel EG, Lüscher TF. Nitric oxide modulates expression of cell cycle regulatory proteins: A cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation 2000;101:1982-9. (Pubitemid 30225281)
8. Qiu C, Muchant D, Beierwaltes WH, Racusen L, Baylis C. Evolution of chronic nitric oxide inhibition hypertension: Relationship to renal function. Hypertension 1998;31:21-6. (Pubitemid 28124686)
9. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-42.
10. Jorgensen RG, Russo L, Mattioli L, Moore WV. Early detection of vascular dysfunction in type I diabetes. Diabetes 1988;37:292-6. (Pubitemid 18065055)
11. Marfella R, Verrazzo G, Acampora R, La Marca C, Giunta R, Lucarelli C, et al. Glutathione reverses systemic hemodynamic changes by acute hyperglycemia in healthy subjects. Am J Physiol 1995;268:E1167-73.
12. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium dependent vasodilation of brachial artery. J Am Coll Cardiol 1999;34:146-54.
13. Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 1997;95:1783-90. (Pubitemid 27164394)
14. Monti LD, Barlassina C, Citterio L, Galluccio E, Berzuini C, Setola E, et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 2003;52:1270-5. (Pubitemid 36523367)
15. Lyamina NP, Dolotovskaya PV, Lyamina SV, Malyshev IY, Manukhina EB. Nitric oxide production and intensity of free radical processes in young men with high normal and hypertensive blood pressure. Med Sci Monit 2003;9:CR304-10. (Pubitemid 37021466)
16. Takase H, Sugiyama M, Nakazawa A, Sato K, Ueda R, Dohi Y. Long-term effect of antihypertensive therapy with calcium antagonist or angiotensin converting enzyme inhibitor on serum nitrite/nitrate levels in human essential hypertension. Arzneimittelforschung 2000;50:530-4. (Pubitemid 30418408)
17. Li R, Lyn D, Lapu-Bula R, Oduwole A, Igho-Pemu P, Lankford B, et al. Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function and blood pressure in African Americans. Am. J Hypertens 2004;17:560-7. (Pubitemid 38844981)
18. Dominiczak AF, Bohr DF. Nitric oxide and its putative role in hypertension. Hypertension 1995;25:1207-8.
19. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, et al. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 1995;26:854-7.
20. Tschudi MR, Mesaros S, Luscher TF, Malinski T. Direct in situ measurement of nitric oxide in mesenteric resistance arteries: Increased decomposition by superoxide in hypertension. Hypertension 1996;27:32-35. (Pubitemid 26017677)
21. Sagar S, Kallo IJ, Nalini K, Ganguly NK, Sharma BK. Oxygen free radicals in essential hypertension. Mol Cell Biochem 1992;111:103-8.
22. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-42.
23. Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Isimer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: Effects of glycemic control. Clin Biochem 2001;34:65-70. (Pubitemid 32178508)
24. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium dependent vasodilatation in experimental diabetes. J Clin Invest 1991;87:432-8.
25. Tesfamariam B, Palacino JJ, Weisbrod RM, Cohen RA. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J Cardiovasc Pharmacol 1993;21:205-211. (Pubitemid 23027595)
26. Williams B, Gallacher B, Patel H, Orme C. Glucose induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 1997;46:1497-503. (Pubitemid 27369089)
27. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001;88: E14-22.
28. Thronalley PJ, McLellan AC, Lo TW, Benn J, Sönksen PH. Negative association between erythrocyte reduced glutathione concentration and diabetic complications. Clin Sci 1996;91:575-82. (Pubitemid 26377612)
29. Jan SK, McVie R. Effect of glycemic control, race (white versus black), and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients. Metabolism 1994;43:306-9. (Pubitemid 24100499)
30. Frei B. Reactive oxygen species and antioxidant vitamins: Mechanism of action. Am J Med 1994;97:5S-13S.
31. Donnini D, Zambito AM, Perrella G, Ambesi-Impiombato FS, Curcio F. Glucose may induce cell death through a free radical-mediated mechanism. Biochem Biophys Res Commun 1996;219:412-7. (Pubitemid 26090285)
32. Pieper GM, Langenstroer P, Siebeneich W. Diabetic-induced endothelial dysfunction in rat aorta: Role of hydroxyl radicals. Cardiovasc Res 1997;34:145-56. (Pubitemid 27261923)
33. Vanizor B, Orem A, Karahan SC, Kiran E, Erem C, Aliyazicioglu R, et al. Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications. Diabetes Res Clin Pract 2001;54:33-9. (Pubitemid 32782641)
34. Mikiwa K, Tadashi I, Kayoko K, Atsushi N, Masahito H, Hiroshi H, et al. Plasma nitrate/nitrite concentration in healthy population and patients with diabetes mellitus- relationships with gender, aging and diabetic complications. Bull Osaka Med Coll 2002;48:1-6.
35. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001;88: E14-22.
36. Mohamed AK, Bierhaus A, Schiekofer S. The role of oxidative stress and NFkappa B activation in late diabetic complications. Biofactors 1999;10:157-67. (Pubitemid 29533824)
37. Tretjakovs P, Kalnins U, Dabina I, Erglis A, Dinne I, Jurka A, et al. Nitric oxide production and arachidonic acid metabolism in platelet membranes of coronary heart disease patients with and without diabetes. Med Princ Pract 2003;12:10-6. (Pubitemid 36164648)
38. Bulent S, Cahit K, Dilek T, Akan AL, Sozmen EY. Plasma antioxidant status and nitrate levels in patients with hypertension and coronary heart disease. Tr J Med Sci 1998;28:525-31.
39. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol 2001;12:383-9. (Pubitemid 32675498)